AI-generated analysis. Always verify with the original filing.
Novo Nordisk A/S reports transactions under its share repurchase programme initiated on 4 February 2026, with 6,577,992 B shares repurchased for DKK 1,783,540,174 at an average price of DKK 271.14 as of 13 March 2026. This is part of a DKK 15 billion programme over 12 months, resulting in 23,967,791 treasury B shares equal to 0.5% of share capital.